deprenyl

(redirected from EMSAM)
Also found in: Medical, Acronyms, Wikipedia.

deprenyl

(ˈdɛprəˌnɪl)
n
a drug used to treat senile dementia, Parkinson's disease, Alzheimer's disease, and depression, by acting as a monoamine oxidase inhibitor
References in periodicals archive ?
Portland of Mylan Specialty, Basking Ridge, N.J., which markets Emsam.
The FDA recently approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression.
The patch will be marketed under the name Emsam and will be available in three sizes that deliver 6, 9, or 12 milligrams of selegiline over 24 hours.
* Comment: In two studies of 400 outpatients with major depressive disorder, those treated with the Emsam patch for 6-8 weeks had significantly more improvement in a depression rating scale than did those on placebo.